125 related articles for article (PubMed ID: 31540955)
1. The Parkinson's disease gene
Furlong RM; Lindsay A; Anderson KE; Hawkins PT; Sullivan AM; O'Neill C
J Cell Sci; 2019 Oct; 132(20):. PubMed ID: 31540955
[TBL] [Abstract][Full Text] [Related]
2. Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP
Boonying W; Joselin A; Huang E; Qu D; Safarpour F; Iyirhiaro GO; Gonzalez YR; Callaghan SM; Slack RS; Figeys D; Chung YH; Park DS
J Neurochem; 2019 Aug; 150(3):312-329. PubMed ID: 30734931
[TBL] [Abstract][Full Text] [Related]
3. Alterations in α-synuclein and PINK1 expression reduce neurite length and induce mitochondrial fission and Golgi fragmentation in midbrain neurons.
Furlong RM; O'Keeffe GW; O'Neill C; Sullivan AM
Neurosci Lett; 2020 Feb; 720():134777. PubMed ID: 31978495
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
5. A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2.
Murata H; Sakaguchi M; Jin Y; Sakaguchi Y; Futami J; Yamada H; Kataoka K; Huh NH
J Biol Chem; 2011 Mar; 286(9):7182-9. PubMed ID: 21177249
[TBL] [Abstract][Full Text] [Related]
6. δ-Opioid Receptor Activation Attenuates Hypoxia/MPP
Xu Y; Zhi F; Peng Y; Shao N; Khiati D; Balboni G; Yang Y; Xia Y
Mol Neurobiol; 2019 Jan; 56(1):252-266. PubMed ID: 29687347
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
[TBL] [Abstract][Full Text] [Related]
8. Genetic mutations and functions of PINK1.
Kawajiri S; Saiki S; Sato S; Hattori N
Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
[TBL] [Abstract][Full Text] [Related]
9. Conformational sampling of membranes by Akt controls its activation and inactivation.
Lučić I; Rathinaswamy MK; Truebestein L; Hamelin DJ; Burke JE; Leonard TA
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3940-E3949. PubMed ID: 29632185
[TBL] [Abstract][Full Text] [Related]
10. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
[TBL] [Abstract][Full Text] [Related]
11. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
12. PINK1 signalling in cancer biology.
O'Flanagan CH; O'Neill C
Biochim Biophys Acta; 2014 Dec; 1846(2):590-8. PubMed ID: 25450579
[TBL] [Abstract][Full Text] [Related]
13. Structure of autoinhibited Akt1 reveals mechanism of PIP
Truebestein L; Hornegger H; Anrather D; Hartl M; Fleming KD; Stariha JTB; Pardon E; Steyaert J; Burke JE; Leonard TA
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385319
[TBL] [Abstract][Full Text] [Related]
14. Endomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway.
Jethwa N; Chung GH; Lete MG; Alonso A; Byrne RD; Calleja V; Larijani B
J Cell Sci; 2015 Sep; 128(18):3456-65. PubMed ID: 26240177
[TBL] [Abstract][Full Text] [Related]
15. S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models.
Oh CK; Sultan A; Platzer J; Dolatabadi N; Soldner F; McClatchy DB; Diedrich JK; Yates JR; Ambasudhan R; Nakamura T; Jaenisch R; Lipton SA
Cell Rep; 2017 Nov; 21(8):2171-2182. PubMed ID: 29166608
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T-cell development and function.
Ellis GI; Zhi L; Akundi R; Büeler H; Marti F
Eur J Immunol; 2013 Dec; 43(12):3355-60. PubMed ID: 24037540
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells.
Maj MC; Tkachyova I; Patel P; Addis JB; Mackay N; Levandovskiy V; Lee J; Lang AE; Cameron JM; Robinson BH
Biochem Biophys Res Commun; 2010 Aug; 399(3):331-5. PubMed ID: 20637729
[TBL] [Abstract][Full Text] [Related]
18. The Interplay between Calmodulin and Membrane Interactions with the Pleckstrin Homology Domain of Akt.
Agamasu C; Ghanam RH; Xu F; Sun Y; Chen Y; Saad JS
J Biol Chem; 2017 Jan; 292(1):251-263. PubMed ID: 27872186
[TBL] [Abstract][Full Text] [Related]
19. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease-associated PINK1 G309D mutation increases abnormal phosphorylation of Tau.
Ye M; Zhou D; Zhou Y; Sun C
IUBMB Life; 2015 Apr; 67(4):286-90. PubMed ID: 25899925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]